Vice President, Manufacturing (Reagents & Consumables)

Organization
NanoString Technologies
Job Location
500 Fairview Ave N
Seattle
WA, WA 98109
Salary
Competitive
Benefits

Comprehensive

Job Description

Job Summary:

The Vice President, Manufacturing is responsible for all Consumables and Reagents Manufacturing at NanoString.  This includes both the Consumables Production and the CodeSet Production teams.   In addition, the Manufacturing Development team reports to the Vice President, Manufacturing.  This person is responsible for all of the following:  on-time delivery of products to customers, maintenance of product inventory, product costs of goods sold (COGS), overhead absorption, process validation, process improvement, effective design transfer of new products into Manufacturing and conformance to all applicable ISO-13485 and FDA QSR/GMP requirements. 

Essential Functions:

  • Lead a team of Managers and Directors in efficient and high quality production of Consumables and Reagents
  • Maintain adequate product inventory for both Finished Goods and key Intermediates
  • Ensure both revenue and customer satisfaction goals are met
  • Work closely with quality groups to ensure compliance with FDA’s QSR and Good Manufacturing Practices (GMP), and ISO-13485 standards at all times
  • Prepare and present metrics, data and reports to senior management, as needed
  • Review and approve process changes and reports, as needed
  • Ensure the effective use of staff, materials and equipment in producing quality products
  • Partner with Finance to review and revise product standard costs annually
  • Maintain budget and approve expenditures, including hiring requests and offers
  • Formulate and recommend manufacturing policies, procedures and programs

 

Requirements

Job Summary:

The Vice President, Manufacturing is responsible for all Consumables and Reagents Manufacturing at NanoString.  This includes both the Consumables Production and the CodeSet Production teams.   In addition, the Manufacturing Development team reports to the Vice President, Manufacturing.  This person is responsible for all of the following:  on-time delivery of products to customers, maintenance of product inventory, product costs of goods sold (COGS), overhead absorption, process validation, process improvement, effective design transfer of new products into Manufacturing and conformance to all applicable ISO-13485 and FDA QSR/GMP requirements. 

Essential Functions:

  • Lead a team of Managers and Directors in efficient and high quality production of Consumables and Reagents
  • Maintain adequate product inventory for both Finished Goods and key Intermediates
  • Ensure both revenue and customer satisfaction goals are met
  • Work closely with quality groups to ensure compliance with FDA’s QSR and Good Manufacturing Practices (GMP), and ISO-13485 standards at all times
  • Prepare and present metrics, data and reports to senior management, as needed
  • Review and approve process changes and reports, as needed
  • Ensure the effective use of staff, materials and equipment in producing quality products
  • Partner with Finance to review and revise product standard costs annually
  • Maintain budget and approve expenditures, including hiring requests and offers
  • Formulate and recommend manufacturing policies, procedures and programs
  • Select, develop, and evaluate personnel to ensure the effective and efficient operations
About Our Organization

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.